Document is current
Any future updates will be listed below
-
Authors
Kato, Yuta
Okada, Atsushi https://orcid.org/0000-0002-0087-4168
Amaki, Makoto
Nishimura, Kunihiro
Kanzaki, Hideaki
Kataoka, Yu
Miyamoto, Koji
Hamatani, Yasuhiro
Amano, Masashi
Takahama, Hiroyuki
Hasegawa, Takuya
Kusano, Kengo
Fujita, Tomoyuki
Kobayashi, Junjiro
Yasuda, Satoshi
Izumi, Chisato
- License Information
-
More Information
Article History
Received: 28 September 2020
Revised: 25 November 2021
Accepted: 9 January 2022
First Online: 27 January 2022
Declarations
:
: Atsushi Okada has received honoraria from Pfizer Inc., Daiichi Sankyo Co. Ltd., Alnylam Inc., Otsuka Pharmaceutical Co. Ltd., and research funding from Novartis. Makoto Amaki has received honoraria and manuscript fees from Abbott Medical. Hiroyuki Takahama has received honoraria from Novartis and Ono Pharmaceutical Co. Ltd. Kengo Kusano has received honoraria from Medtronic Japan Co. Ltd., Daiichi Sankyo Co. Ltd., Bristol-Myers Squibb Co., Bayer Yakuhin Ltd., Boston Scientific Co., and research funding from EP-CRSU Co. Ltd. Satoshi Yasuda has received research funding from Abbott Japan and Takeda Pharmaceutical Co. Ltd. Yuta Kato, Kunihiro Nishimura, Hideaki Kanzaki, Yu Kataoka, Koji Miyamoto, Yasuhiro Hamatani, Masashi Amano, Takuya Hasegawa, Tomoyuki Fujita, Junjiro Kobayashi and Chisato Izumi declare that they have no conflict of interest.
: All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later revisions.
: Informed consent was obtained in an opt-out format from all patients included in the study.
